Helus Pharma director Lawson holds 3,026 shares directly

Rhea-AI Filing Summary

Helus Pharma Inc. (HELP) reports director Mark Lawson’s common-share holdings as of October 13, 2026: 3,026 shares held directly and 157,000 shares held by Four Paths Partners Ltd. The second entry identifies Four Paths Partners Ltd. as the holder and states that Lawson owns and controls the corporation. The positions are presented separately.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Lawson Mark

Role Director

Type	Security	Shares	Price	Value
holding	Common Shares	--	--	--
holding	Common Shares F1	--	--	--

Holdings After Transaction: Common Shares — 3,026 shares (Direct); Common Shares — 157,000 shares (Indirect, Held by Four Paths Partners Ltd.)

Footnotes (1)

1. F1. Held by Four Paths Partners Ltd., a corporation owned and controlled by the reporting person.

Key Figures

Common shares held directly: 3,026 shares Common shares held by Four Paths Partners Ltd.: 157,000 shares

2 metrics

Common shares held directly 3,026 shares Mark Lawson, as of October 13, 2026

Common shares held by Four Paths Partners Ltd. 157,000 shares Corporation owned and controlled by Mark Lawson, as of October 13, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HELP shares did director Mark Lawson report holding?

Mark Lawson reported 3,026 common shares held directly and 157,000 common shares held by Four Paths Partners Ltd. as of October 13, 2026. The accompanying note says Lawson owns and controls the corporation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/23/2026 - 07:13 PM EDT Accepted by SEC EDGAR 10/23/2026 - 07:13 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lawson Mark

(Last) (First) (Middle)

C/O HELUS PHARMA INC.

100 KING STREET WEST, SUITE 5600

(Street)

TORONTO M5X 1C9

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
10/13/2026

3. Issuer Name and Ticker or Trading Symbol
Helus Pharma Inc. [ HELP ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	3,026	D
Common Shares	157,000	I	Held by Four Paths Partners Ltd.(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Held by Four Paths Partners Ltd., a corporation owned and controlled by the reporting person.

	/s/ Mark Lawson	10/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)